We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The Public Health England (PHE) Special Edition Vaccine Update July 2017 advises that there is currently sufficient stock of Intervax BCG vaccine to extend the offer of vaccination to all eligible groups as follows:
Highest Priority
a) All infants (aged 0 to 12 months) with a parent or grandparent who was born in a country where the annual incidence of TB is 40/100,000 or greater.
b) All infants (aged 0 to 12 months) living in areas of the UK where the annual incidence of TB is 40/100,000 or greater.
c) Previously unvaccinated children aged one to five years:
Moderate Priority
d) Previously unvaccinated, tuberculin-negative children aged from six to under 16 years of age with a parent or grandparent who was born in a country where the annual incidence of TB is 40/100,000 or greater. These children should be identified at suitable opportunities, tuberculin tested and vaccinated if negative as per the Green Book section on tuberculin testing prior to BCG vaccination.
e) Previously unvaccinated tuberculin-negative individuals under 16 years of age who are contacts of cases of respiratory TB (following NICE recommended contact management advice).
f) Previously unvaccinated, tuberculin-negative individuals under 16 years of age who were born in or who have lived for a prolonged perio (at least three months) in a country with an annual TB incidence of 40/100,000 or greater.
g) Previously unvaccinated, tuberculin-negative individuals under 16 years of age who are going to live or work with local people for more than three months in a country where the annual incidence of TB is 40/100,000 or greater.
Lowest Priority
h) Individuals at occupational risk.